With the advent of advanced laboratory tests that offer further prognostic information, the international workshop on CLL (iwCLL) guidelines were revised in 2018 and now include routine testing of FISH, TP53 sequencing, and IGHV in patients who are being considered for treatment [28]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.